Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more
Cochlear Limited (CHEOF) - Total Assets
Latest total assets as of June 2025: $2.83 Billion USD
Based on the latest financial reports, Cochlear Limited (CHEOF) holds total assets worth $2.83 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cochlear Limited - Total Assets Trend (1996–2025)
This chart illustrates how Cochlear Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cochlear Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Cochlear Limited's total assets of $2.83 Billion consist of 50.2% current assets and 49.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.8% |
| Accounts Receivable | $585.90 Million | 20.7% |
| Inventory | $499.40 Million | 17.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $222.20 Million | 7.9% |
| Goodwill | $278.60 Million | 9.9% |
Asset Composition Trend (1996–2025)
This chart illustrates how Cochlear Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cochlear Limited's current assets represent 50.2% of total assets in 2025, a decrease from 73.0% in 1996.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 33.3% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 20.7% of total assets.
Cochlear Limited Competitors by Total Assets
Key competitors of Cochlear Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Cochlear Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cochlear Limited generates 0.83x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Cochlear Limited generates $ 13.77 in net profit.
Cochlear Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.35 | 2.30 | 1.81 |
| Quick Ratio | 1.52 | 1.68 | 1.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $814.50 Million | $ 820.60 Million | $ 660.00 Million |
Cochlear Limited - Advanced Valuation Insights
This section examines the relationship between Cochlear Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.56 |
| Latest Market Cap to Assets Ratio | 3.66 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | $2.83 Billion |
| Market Capitalization | $10.33 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Cochlear Limited's assets at a significant premium ( 3.66x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Cochlear Limited's assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Cochlear Limited (1996–2025)
The table below shows the annual total assets of Cochlear Limited from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $2.83 Billion | +2.91% |
| 2024-06-30 | $2.75 Billion | +6.87% |
| 2023-06-30 | $2.57 Billion | +4.20% |
| 2022-06-30 | $2.47 Billion | +1.10% |
| 2021-06-30 | $2.44 Billion | -5.34% |
| 2020-06-30 | $2.58 Billion | +86.75% |
| 2019-06-30 | $1.38 Billion | +19.22% |
| 2018-06-30 | $1.16 Billion | +1.81% |
| 2017-06-30 | $1.14 Billion | +18.70% |
| 2016-06-30 | $957.36 Million | +10.16% |
| 2015-06-30 | $869.06 Million | +10.14% |
| 2014-06-30 | $789.04 Million | +3.21% |
| 2013-06-30 | $764.50 Million | +8.82% |
| 2012-06-30 | $702.54 Million | -5.20% |
| 2011-06-30 | $741.05 Million | -1.42% |
| 2010-06-30 | $751.72 Million | +10.65% |
| 2009-06-30 | $679.37 Million | +11.75% |
| 2008-06-30 | $607.92 Million | +3.79% |
| 2007-06-30 | $585.74 Million | +7.29% |
| 2006-06-30 | $545.92 Million | +7.94% |
| 2005-06-30 | $505.75 Million | +91.18% |
| 2004-06-30 | $264.54 Million | +14.73% |
| 2003-06-30 | $230.58 Million | +43.73% |
| 2002-06-30 | $160.43 Million | +24.32% |
| 2001-06-30 | $129.05 Million | +37.62% |
| 2000-06-30 | $93.77 Million | +13.06% |
| 1999-06-30 | $82.94 Million | +20.00% |
| 1998-06-30 | $69.11 Million | +34.76% |
| 1997-06-30 | $51.29 Million | +6.31% |
| 1996-06-30 | $48.24 Million | -- |